Codexis Invests In Arzeda
Codexis and existing Series A investor Casdin Capital co-invest in Arzeda as part of the SynBio Innovation Accelerator, alongside plans for Codexis and Arzeda to collaborate on areas of synergy and mutual advantage.
← All newsSEATTLE (Nov. 24, 2020) – Codexis and existing Series A investor, Casdin Capital, have co-invested in Arzeda as part of the SynBio Innovation Accelerator. In addition to the capital investment, Codexis and Arzeda look forward to collaborate on areas of synergy and mutual advantage. Press release from Codexis and Casdin Capital available here.